Lymphoma Follicular

Top drugs studied for this disease

EMA withdrawal · 2023-07-10
EMA Withdrawn: Lenalidomide Krka d.d. (lenalidomide hydrochloride hydrate) — Krka, d.d., Novo mesto
The EMA withdrew lenalidomide hydrochloride hydrate (Krka) from the market for multiple indications including multiple myeloma, follicular l…
EMA withdrawal · 2022-12-15
EMA Withdrawn: IntronA (interferon alfa-2b) — Merck Sharp & Dohme B.V.
The European Medicines Agency has withdrawn IntronA (interferon alfa-2b) from the market.